{"entity":{"type":"insider","cik":"0001572691","url":"/insider/0001572691","json_url":"/insider/0001572691.json","name":"Reinisch Richard","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":1,"first":"2013-03-22","last":"2013-03-22","span_basis":"filed_date"},"name_variants":[{"name":"Reinisch Richard","source":"filing","n_filings":1,"first_seen":"2013-03-22","last_seen":"2013-03-22"}],"transactions":[{"id":5496172,"accession":"0001019056-13-000425","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001019056-13-000425","line_url":"/filing/0001019056-13-000425","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":"0001572691","owner_name":"Reinisch Richard","owner_display_name":"Reinisch Richard","owner_url":"/insider/0001572691","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"La Jolla Pharmaceutical Company","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":0.09176,"price_display":"0.09","price_state":"stated","total_value":9176.0,"total_display":"9,176.00","total_whole":"9,176","shares_owned_after":1080000.0,"shares_owned_after_display":"1,080,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-19","filed_date":"2013-03-22","scope":"insider","n_lines":2},{"id":5496168,"accession":"0001019056-13-000425","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001019056-13-000425","line_url":"/filing/0001019056-13-000425#line-6","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":"0001572691","owner_name":"Reinisch Richard","owner_display_name":"Reinisch Richard","owner_url":"/insider/0001572691","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"La Jolla Pharmaceutical Company","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":220695.0,"shares_display":"220,695","price_per_share":0.0967,"price_display":"0.10","price_state":"stated","total_value":21341.2065,"total_display":"21,341.21","total_whole":"21,341","shares_owned_after":1000000.0,"shares_owned_after_display":"1,000,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-02","filed_date":"2013-03-22","scope":"insider"},{"id":5496165,"accession":"0001019056-13-000425","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001019056-13-000425","line_url":"/filing/0001019056-13-000425#line-5","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":"0001572691","owner_name":"Reinisch Richard","owner_display_name":"Reinisch Richard","owner_url":"/insider/0001572691","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"La Jolla Pharmaceutical Company","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":279305.0,"shares_display":"279,305","price_per_share":0.0952,"price_display":"0.10","price_state":"stated","total_value":26589.836,"total_display":"26,589.84","total_whole":"26,590","shares_owned_after":779305.0,"shares_owned_after_display":"779,305","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-01","filed_date":"2013-03-22","scope":"insider"},{"id":5496164,"accession":"0001019056-13-000425","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001019056-13-000425","line_url":"/filing/0001019056-13-000425#line-4","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":"0001572691","owner_name":"Reinisch Richard","owner_display_name":"Reinisch Richard","owner_url":"/insider/0001572691","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"La Jolla Pharmaceutical Company","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":121200.0,"shares_display":"121,200","price_per_share":0.09,"price_display":"0.09","price_state":"stated","total_value":10908.0,"total_display":"10,908.00","total_whole":"10,908","shares_owned_after":500000.0,"shares_owned_after_display":"500,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-25","filed_date":"2013-03-22","scope":"insider"},{"id":5496162,"accession":"0001019056-13-000425","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001019056-13-000425","line_url":"/filing/0001019056-13-000425#line-3","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":"0001572691","owner_name":"Reinisch Richard","owner_display_name":"Reinisch Richard","owner_url":"/insider/0001572691","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"La Jolla Pharmaceutical Company","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":144780.0,"shares_display":"144,780","price_per_share":0.0897,"price_display":"0.09","price_state":"stated","total_value":12986.766,"total_display":"12,986.77","total_whole":"12,987","shares_owned_after":378800.0,"shares_owned_after_display":"378,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-24","filed_date":"2013-03-22","scope":"insider"},{"id":5496159,"accession":"0001019056-13-000425","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001019056-13-000425","line_url":"/filing/0001019056-13-000425#line-2","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":"0001572691","owner_name":"Reinisch Richard","owner_display_name":"Reinisch Richard","owner_url":"/insider/0001572691","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"La Jolla Pharmaceutical Company","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":234000.0,"shares_display":"234,000","price_per_share":0.077,"price_display":"0.08","price_state":"stated","total_value":18018.0,"total_display":"18,018.00","total_whole":"18,018","shares_owned_after":234020.0,"shares_owned_after_display":"234,020","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-23","filed_date":"2013-03-22","scope":"insider"},{"id":5496156,"accession":"0001019056-13-000425","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001019056-13-000425","line_url":"/filing/0001019056-13-000425#line-1","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":"0001572691","owner_name":"Reinisch Richard","owner_display_name":"Reinisch Richard","owner_url":"/insider/0001572691","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"La Jolla Pharmaceutical Company","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20.0,"shares_display":"20","price_per_share":936.1975,"price_display":"936.20","price_state":"stated","total_value":18723.95,"total_display":"18,723.95","total_whole":"18,724","shares_owned_after":20.0,"shares_owned_after_display":"20","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-12","filed_date":"2013-03-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000920465","name":"LA JOLLA PHARMACEUTICAL CO","url":"/issuer/0000920465","role":"Other","n_filings":1,"first_seen":"2013-03-22","last_seen":"2013-03-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001572691","retrieved_at":"2026-08-26T16:43:40+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}